BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32585678)

  • 21. The effect of PPIs Alone, PPIs plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial.
    Lee JY; Jang JS
    Arab J Gastroenterol; 2021 Jun; 22(2):115-120. PubMed ID: 33551349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Delayed Ulcer Healing after Endoscopic Submucosal Dissection of Gastric Neoplasms.
    Shimozato A; Sasaki M; Ogasawara N; Funaki Y; Ebi M; Tamura Y; Izawa S; Hijikata Y; Yamaguchi Y; Kasugai K
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):363-368. PubMed ID: 29253050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of mucoprotective agents in endoscopic submucosal dissection-derived ulcers: A systematic review.
    Pittayanon R; Martel M; Barkun A
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1948-1955. PubMed ID: 29870582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2020 Feb; 99(9):e19357. PubMed ID: 32118778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
    Ko J; Kim SJ; Kang DH; Choi CW; Kim HW; Park SB
    Medicine (Baltimore); 2019 May; 98(20):e15701. PubMed ID: 31096515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Vonoprazan on Delayed Bleeding after Endoscopic Submucosal Dissection for Gastric Neoplasia among Antithrombotic Drug Users: A Single-Center, Single-Arm Prospective Observational Case Control Study.
    Yamamoto S; Takayama H; Shimodate Y; Takezawa R; Nishimura N; Doi A; Mouri H; Matsueda K; Mizuno M; Okada H
    Acta Med Okayama; 2020 Jun; 74(3):245-250. PubMed ID: 32577023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
    Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
    Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of administration of a proton pump inhibitor before endoscopic submucosal dissection for differentiated early gastric cancer with ulcer.
    Myung YS; Hong SJ; Han JP; Park KW; Ko BM; Lee MS
    Gastric Cancer; 2017 Jan; 20(1):200-206. PubMed ID: 26661593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
    Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
    Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of administration of a proton pump inhibitor for ulcerative differentiated early gastric cancer prior to endoscopic submucosal dissection.
    Wang J; Shan F; Li S; Li Z; Wu Q
    Dig Endosc; 2021 Sep; 33(6):939-947. PubMed ID: 33184984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of proton pump inhibitors and potassium competitive acid blockers against post-gastric endoscopic submucosal dissection bleeding: a single-center, propensity score-matched analysis.
    Toya Y; Endo M; Sugai K; Yamada S; Oizumi T; Morishita T; Akasaka R; Yanai S; Nakamura S; Eizuka M; Uesugi N; Sugai T; Matsumoto T
    Scand J Gastroenterol; 2021 Feb; 56(2):199-204. PubMed ID: 33332216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
    Nakamura K; Ihara E; Akiho H; Akahoshi K; Harada N; Ochiai T; Nakamura N; Ogino H; Iwasa T; Aso A; Iboshi Y; Takayanagi R
    Gut Liver; 2016 Nov; 10(6):917-924. PubMed ID: 27282261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2019 Feb; 98(8):e14381. PubMed ID: 30813139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of fibrin sealant as hemostatic technique in accelerating ESD-induced ulcer healing: a retrospective study.
    Wang J; Wu Q; Yan Y; Li SJ; Yuan P; Cao CQ; Niu DF; Li ZY; Bu ZD; Ji JF
    Surg Endosc; 2020 Mar; 34(3):1191-1199. PubMed ID: 31236721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.
    Lee SH; Lee CK; Chung IK; Shim YS; Lee TH; Lee SH; Kim HS; Park SH; Kim SJ
    Dig Dis Sci; 2012 Feb; 57(2):429-34. PubMed ID: 22001942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Related to Delayed Adverse Events of Endoscopic Submucosal Dissection in the Duodenum.
    Kawamura T; Hirose T; Kakushima N; Furukawa K; Furune S; Ishikawa E; Sawada T; Keiko M; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Honda T; Ishigami M; Kawashima H; Fujishiro M
    Dig Dis; 2023; 41(1):80-88. PubMed ID: 35108704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percent reduction of the ulcer size at 4 weeks is a predictor of the complete healing of endoscopic submucosal dissection-induced gastric ulcers.
    Uchida E; Kato S; Tsuchiya I; Ohkuma K; Taniguchi L; Tanida E; Masui Y; Yoshizawa K; Nakajima A; Izumi M
    Arab J Gastroenterol; 2020 Sep; 21(3):183-188. PubMed ID: 32798188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of oral and intravenous lansoprazole for the prevention of bleeding from artificial ulcers after endoscopic submucosal dissection for gastric tumors: a prospective randomized phase II study (KDOG 0802).
    Ishido K; Tanabe S; Azuma M; Katada C; Wada T; Yano T; Koizumi W
    Surg Endosc; 2018 Jun; 32(6):2939-2947. PubMed ID: 29273872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect on Bleeding Prevention of an Intravenous Proton Pump Inhibitor During the Fasting Period After Endoscopic Submucosal Dissection: a Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
    Yoon JH; Kim YJ; Lee KN; Jun DW; Koh DH; Lee HL
    J Gastrointest Surg; 2020 Nov; 24(11):2596-2601. PubMed ID: 31845139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.